PROmotion of Breastfeeding Intervention Trial

Not Applicable

Completed

• Conditions: Healthy, full-term, breastfed infants; Breastfeeding; Pregnancy and Childbirth

• Registration Number: ISRCTN37687716
• Lead Sponsor: McGill University (Canada)

Brief Summary

1. 2007 results in: http://www.ncbi.nlm.nih.gov/pubmed/17855282 2. 2007 results in: http://www.ncbi.nlm.nih.gov/pubmed/18065591 3. 2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/18310164 4. 2008 results in: http://www.ncbi.nlm.nih.gov/pubmed/18458209 5. 2011 results in: http://www.ncbi.nlm.nih.gov/pubmed/21633072 6. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23483175 7. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/23776123 8. 2013 results in: http://www.ncbi.nlm.nih.gov/pubmed/24300437 9. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24706729 10. 2014 results in: http://www.ncbi.nlm.nih.gov/pubmed/24787489 11. 2014 cohort profile in: http://www.ncbi.nlm.nih.gov/pubmed/23471837 12. 2017 secondary analysis results in: http://www.ncbi.nlm.nih.gov/pubmed/28459932 13. 2018 secondary analysis results in: http://www.ncbi.nlm.nih.gov/pubmed/29635502 14. 2019 secondary analysis results in https://www.ncbi.nlm.nih.gov/pubmed/29618044 (added 29/01/2020) 15. 2019 secondary analysis results in https://pubmed.ncbi.nlm.nih.gov/31081565/ (added 15/09/2020) 16. 2021 results in https://pubmed.ncbi.nlm.nih.gov/32743654/ (added 03/06/2021)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-09-09
• Study Completion: 2015-12-31
• Last Update Posted: 14 June 2021

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 17046

Inclusion Criteria

1. Birth weight equal and above 2500 g, either sex
2. Gestational age equal and above 37 weeks
3. Maternal intention to breastfeed

Exclusion Criteria

1. Neonatal disease or condition contraindicating breastfeeding
2. Neonatal disease or condition making breastfeeding difficult or impossible
3. Maternal psychosis
4. Maternal human immunodeficiency virus (HIV) or active tuberculosis (TB)
5. Maternal chemotherapy or radioisotopes

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
One or more episodes of gastrointestinal infection in first 12 months of life.